Collection of Blood for Multiple Collaborative Studies
| Status: | Recruiting |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/17/2018 |
| Start Date: | January 1988 |
| End Date: | January 2020 |
| Contact: | Rebecca Hoh, M.S., R.D. |
| Email: | Rebecca.Hoh@ucsf.edu |
| Phone: | 415-476-4082 |
Collection and Preservation of Blood and Serum Specimens From HIV Positive or HIV Negative Patients for Multiple Collaborative Studies
This study seeks to confidentially collect blood from HIV-positive individuals and
HIV-negative controls to provide basic scientists with specimens for collaborative studies.
HIV-negative controls to provide basic scientists with specimens for collaborative studies.
HIV positive patients are currently the focus of multiple collaborative research studies,
both at UCSF and other institutions. The aims of these research projects include improving
the understanding of etiology, immunology, epidemiology and treatment of HIV. There are
numerous requests from basic scientists at UCSF for collaborative studies on specimens,
especially for blood, saliva and urine samples. Specimens may be used to test such things as
virus characteristics, genotyping and/or phenotyping resistance, plasma drug concentrations,
immune function or evidence of complications of HIV disease. The samples may also be tested
for genetic factors that may be related to the course of HIV disease
both at UCSF and other institutions. The aims of these research projects include improving
the understanding of etiology, immunology, epidemiology and treatment of HIV. There are
numerous requests from basic scientists at UCSF for collaborative studies on specimens,
especially for blood, saliva and urine samples. Specimens may be used to test such things as
virus characteristics, genotyping and/or phenotyping resistance, plasma drug concentrations,
immune function or evidence of complications of HIV disease. The samples may also be tested
for genetic factors that may be related to the course of HIV disease
Inclusion Criteria:
- HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort
- HIV-positive subjects naive to antiretroviral therapy
- HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6
months
- Good venous access
- Able to provide informed consent
Exclusion Criteria:
- Hemoglobin < 9g/dl
- Hematocrit < 27%
- Active treatment for cancer
- Hospitalization or IV antibiotic use within the last 4 months
- Immunosuppressive therapy within the last 4 months
We found this trial at
1
site
San Francisco General Hospital San Francisco General Hospital and Trauma Center (SFGH) is an essential...
Click here to add this to my saved trials
